Treatment Outcomes in Adults with Acute Myeloid Leukemia (AML) Using Standard Induction “3+7”, Hypomethylating Agents or Best Supportive Care: A Single Institution Experience

Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy with diverse genomic aberrations, treatment approaches and outcomes. Anthracycline plus cytarabine remains standard of care in fit patients; hypomethylating agents or supportive care has been suggested for elderly and those with poor performance status.

Source: Clinical Lymphoma, Myeloma and Leukemia - September 1, 2017 Category: Hematology Authors: Bolanle Gbadamosi, Sanjog Bastola, Hong Ye, Daniel Ezekwudo, Foluso Ogunleye, Zhou Yu, Thomas Fennell, Erika Mora, Brian Hart, Susanna Gaikazian, Ishmael Jaiyesimi Source Type: research